sanguiin H 6: a cytotoxic dimeric ellagitannin from Sanguisorba officinalis; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Sanguisorba | genus | A plant genus of the family ROSACEAE. Members contain sanguiin.[MeSH] | Rosaceae | The rose plant family in the order ROSALES and class Magnoliopsida. They are generally woody plants. A number of the species of this family contain cyanogenic compounds.[MeSH] |
| ID Source | ID |
|---|---|
| PubMed CID | 16131123 |
| MeSH ID | M0218238 |
| Synonym |
|---|
| 82978-00-5 |
| alpha-d-glucopyranose, cyclic 4,6-(3-(5-(((2,3:4,6-bis-o-((4,4',5,5',6,6'-hexahydroxy(1,1'-biphenyl)-2,2'-diyl)dicarbonyl)-beta-d-glucopyranosyl)oxy)carbonyl)-2,3-dihydroxyphenoxy)-4,4',5,5',6,6'hexahydroxy(1,1'-biphenyl)-2,2,3-(4,4',5,5',6,6'-hexahydroxy |
| sanguiin h 6 |
| DTXSID401030307 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (22.76) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 13 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||